|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Capitanio U and Montorsi F: Renal cancer.
Lancet. 387:894–906. 2016. View Article : Google Scholar
|
|
3
|
Escudier B, Motzer RJ, Sharma P, Wagstaff
J, Plimack ER, Hammers HJ, Donskov F, Gurney H, Sosman JA, Zalewski
PG, et al: Treatment beyond progression in patients with advanced
renal cell carcinoma treated with nivolumab in CheckMate 025. Eur
Urol. 72:368–376. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wells JC, Stukalin I, Norton C, Srinivas
S, Lee JL, Donskov F, Bjarnason GA, Yamamoto H, Beuselinck B, Rini
BI, et al: Third-line targeted therapy in metastatic renal cell
carcinoma: Results from the International Metastatic Renal Cell
Carcinoma Database Consortium. Eur Urol. 71:204–209. 2017.
View Article : Google Scholar
|
|
5
|
Hu F, Xu P, Sun B and Xiao Z: Differences
in the MicroRNA profiles of subcutaneous adipose-derived stem cells
and omental adipose-derived stem cells. Gene. 625:55–63. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liang L, Lan F, Yin X, Ge S, Yu J and Yan
M: Metal-enhanced fluorescence/visual bimodal platform for
multiplexed ultrasensitive detection of microRNA with reusable
paper analytical devices. Biosens Bioelectron. 95:181–188. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tao Y, Yin D, Jin M, Fang J, Dai T, Li Y,
Li Y, Pu Q and Xie G: Double-loop hairpin probe and
doxorubicin-loaded gold nanoparticles for the ultrasensitive
electrochemical sensing of microRNA. Biosens Bioelectron.
96:99–105. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gattolliat CH, Couvé S, Meurice G, Oréar
C, Droin N, Chiquet M, Ferlicot S, Verkarre V, Vasiliu V, Molinié
V, et al: Integrative analysis of dysregulated microRNAs and mRNAs
in multiple recurrent synchronized renal tumors from patients with
von Hippel-Lindau disease. Int J Oncol. 53:1455–1468.
2018.PubMed/NCBI
|
|
9
|
Yi Z, Fu Y, Zhao S, Zhang X and Ma C:
Differential expression of miRNA patterns in renal cell carcinoma
and nontumorous tissues. J Cancer Res Clin Oncol. 136:855–862.
2010. View Article : Google Scholar
|
|
10
|
Lawrie CH, Larrea E, Larrinaga G,
Goicoechea I, Arestin M, Fernandez-Mercado M, Hes O, Cáceres F,
Manterola L and López JI: Targeted next-generation sequencing and
non-coding RNA expression analysis of clear cell papillary renal
cell carcinoma suggests distinct pathological mechanisms from other
renal tumour subtypes. J Pathol. 232:32–42. 2014. View Article : Google Scholar
|
|
11
|
Falzone L, Candido S, Salemi R, Basile MS,
Scalisi A, McCubrey JA, Torino F, Signorelli SS, Montella M and
Libra M: Computational identification of microRNAs associated to
both epithelial to mesenchymal transition and NGAL/MMP-9 pathways
in bladder cancer. Oncotarget. 7:72758–72766. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hafsi S, Candido S, Maestro R, Falzone L,
Soua Z, Bonavida B, Spandidos DA and Libra M: Correlation between
the overexpression of Yin Yang 1 and the expression levels of
miRNAs in Burkitt’s lymphoma: A computational study. Oncol Lett.
11:1021–1025. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ambade A, Satishchandran A and Szabo G:
Alcoholic hepatitis accelerates early hepatobiliary cancer by
increasing stemness and miR-122-mediated HIF-1α activation. Sci
Rep. 6:213402016. View Article : Google Scholar
|
|
14
|
Elhanati S, Ben-Hamo R, Kanfi Y, Varvak A,
Glazz R, Lerrer B, Efroni S and Cohen HY: Reciprocal regulation
between SIRT6 and miR-122 controls liver metabolism and predicts
hepatocarcinoma prognosis. Cell Reports. 14:234–242. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hopcraft SE, Azarm KD, Israelow B, Lévêque
N, Schwarz MC, Hsu TH, Chambers MT, Sourisseau M, Semler BL and
Evans MJ: Viral determinants of miR-122-independent hepatitis C
virus replication. mSphere. 1:12015.
|
|
16
|
Maierthaler M, Benner A, Hoffmeister M,
Surowy H, Jansen L, Knebel P, Chang-Claude J, Brenner H and
Burwinkel B: Plasma miR-122 and miR-200 family are prognostic
markers in colorectal cancer. Int J Cancer. 140:176–187. 2017.
View Article : Google Scholar
|
|
17
|
Pan C, Wang X, Shi K, Zheng Y, Li J, Chen
Y, Jin L and Pan Z: miR-122 reverses the doxorubicin-resistance in
hepatocellular carcinoma cells through regulating the tumor
metabolism. PLoS One. 11:e01520902016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ahsani Z, Mohammadi-Yeganeh S, Kia V,
Karimkhanloo H, Zarghami N and Paryan M: WNT1 gene from WNT
signaling pathway is a direct target of miR-122 in hepatocellular
carcinoma. Appl Biochem Biotechnol. 181:884–897. 2017. View Article : Google Scholar
|
|
19
|
von Felden J, Heim D, Schulze K, Krech T,
Ewald F, Nashan B, Lohse AW and Wege H: High expression of micro
RNA-135A in hepatocellular carcinoma is associated with recurrence
within 12 months after resection. BMC Cancer. 17:602017. View Article : Google Scholar
|
|
20
|
Fong MY, Zhou W, Liu L, Alontaga AY,
Chandra M, Ashby J, Chow A, O’Connor ST, Li S, Chin AR, et al:
Breast-cancer-secreted miR-122 reprograms glucose metabolism in
premetastatic niche to promote metastasis. Nat Cell Biol.
17:183–194. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee CG, Kim JG, Kim HJ, Kwon HK, Cho IJ,
Choi DW, Lee WH, Kim WD, Hwang SJ, Choi S, et al: Discovery of an
integrative network of microRNAs and transcriptomics changes for
acute kidney injury. Kidney Int. 86:943–953. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Du WW, Yang W, Chen Y, Wu ZK, Foster FS,
Yang Z, Li X and Yang BB: Foxo3 circular RNA promotes cardiac
senescence by modulating multiple factors associated with stress
and senescence responses. Eur Heart J. 38:1402–1412. 2017.
|
|
23
|
Hagenbuchner J, Lungkofler L,
Kiechl-Kohlendorfer U, Viola G, Ferlin MG, Ausserlechner MJ and
Obexer P: The tubulin inhibitor MG-2477 induces autophagy-regulated
cell death, ROS accumulation and activation of FOXO3 in
neuroblastoma. Oncotarget. 8:32009–32026. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kumazoe M, Takai M, Bae J, Hiroi S, Huang
Y, Takamatsu K, Won Y, Yamashita M, Hidaka S, Yamashita S, et al:
FOXO3 is essential for CD44 expression in pancreatic cancer cells.
Oncogene. 36:2643–2654. 2017. View Article : Google Scholar
|
|
25
|
Kumazoe M, Takai M, Hiroi S, Takeuchi C,
Kadomatsu M, Nojiri T, Onda H, Bae J, Huang Y, Takamatsu K, et al:
The FOXO3/PGC-1β signaling axis is essential for cancer stem cell
properties of pancreatic ductal adenocarcinoma. J Biol Chem.
292:10813–10823. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Coomans de Brachène A and Demoulin JB:
FOXO transcription factors in cancer development and therapy. Cell
Mol Life Sci. 73:1159–1172. 2016. View Article : Google Scholar
|
|
27
|
Liang R and Ghaffari S: Mitochondria and
FOXO3 in stem cell homeostasis, a window into hematopoietic stem
cell fate determination. J Bioenerg Biomembr. 49:343–346. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Natarajan SK, Stringham BA, Mohr AM,
Wehrkamp CJ, Lu S, Phillippi MA, Harrison-Findik D and Mott JL:
FoxO3 increases miR-34a to cause palmitate-induced cholangiocyte
lipoapoptosis. J Lipid Res. 58:866–875. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Peng XL, So KK, He L, Zhao Y, Zhou J, Li
Y, Yao M, Xu B, Zhang S, Yao H, et al: MyoD- and FoxO3-mediated
hotspot interaction orchestrates super-enhancer activity during
myogenic differentiation. Nucleic Acids Res. 45:8785–8805. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Salcher S, Hermann M, Kiechl-Kohlendorfer
U, Ausserlechner MJ and Obexer P: C10ORF10/DEPP-mediated ROS
accumulation is a critical modulator of FOXO3-induced autophagy.
Mol Cancer. 16:952017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Song D, Ma J, Chen L, Guo C, Zhang Y, Chen
T, Zhang S, Zhu Z, Tian L and Niu P: FOXO3 promoted mitophagy via
nuclear retention induced by manganese chloride in SH-SY5Y cells.
Metallomics. 9:1251–1259. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lee J and Park SH: Tumor-suppressive
activity of 1,25-dihydroxyvitamin D3 against kidney cancer cells
via up-regulation of FOXO3. Biosci Biotechnol Biochem.
80:1947–1953. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ni D, Ma X, Li HZ, Gao Y, Li XT, Zhang Y,
Ai Q, Zhang P, Song EL, Huang QB, et al: Downregulation of FOXO3a
promotes tumor metastasis and is associated with metastasis-free
survival of patients with clear cell renal cell carcinoma. Clin
Cancer Res. 20:1779–1790. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bloomsmith MA, Perlman JE, Hutchinson E
and Sharpless M: Behavioral management programs to promote
laboratory animal welfare. Management of Animal Care and Use
Programs in Research, Education, and Testing. Weichbrod RH,
Thompson GAH and Norton JN: CRC Press/Taylor & Francis; Boca
Raton, FL: pp. 63–82. 2018
|
|
35
|
Lee C, You D, Park J, Jeong IG, Song C,
Hong JH, Ahn H and Kim CS: Validation of the 2009 TNM
classification for renal cell carcinoma: Comparison with the 2002
TNM classification by concordance index. Korean J Urol. 52:524–530.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ficarra V, Novara G and Martignoni G: The
use of simplified versions of the Fuhrman nuclear grading system in
clinical practice requires the agreement of a multidisciplinary
panel of experts. Eur Urol. 56:782–784; discussion 784–785. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhou Y, Liu Y, Yan H, Li Y, Zhang H, Xu J,
Puthiyakunnon S and Chen X: miR-281, an abundant midgut-specific
miRNA of the vector mosquito Aedes albopictus enhances dengue virus
replication. Parasit Vectors. 7:4882014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wolter JM, Kotagama K, Pierre-Bez AC,
Firago M and Mangone M: 3′LIFE: A functional assay to detect miRNA
targets in high-throughput. Nucleic Acids Res. 42:e1322014.
View Article : Google Scholar
|
|
39
|
Fan Y, Ma X, Li H, Gao Y, Huang Q, Zhang
Y, Bao X, Du Q, Luo G, Liu K, et al: miR-122 promotes metastasis of
clear-cell renal cell carcinoma by downregulating Dicer. Int J
Cancer. 142:547–560. 2018. View Article : Google Scholar
|
|
40
|
Lian JH, Wang WH, Wang JQ, Zhang YH and Li
Y: MicroRNA-122 promotes proliferation, invasion and migration of
renal cell carcinoma cells through the PI3K/Akt signaling pathway.
Asian Pac J Cancer Prev. 14:5017–5021. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Junker K, Heinzelmann J, Beckham C, Ochiya
T and Jenster G: Extracellular vesicles and their role in urologic
malignancies. Eur Urol. 70:323–331. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Qu L, Ding J, Chen C, Wu ZJ, Liu B, Gao Y,
Chen W, Liu F, Sun W, Li XF, et al: Exosome-transmitted lncARSR
promotes sunitinib resistance in renal cancer by acting as a
competing endogenous RNA. Cancer Cell. 29:653–668. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Akuta N, Kawamura Y, Suzuki F, Saitoh S,
Arase Y, Kunimoto H, Sorin Y, Fujiyama S, Sezaki H, Hosaka T, et
al: Impact of circulating miR-122 for histological features and
hepatocellular carcinoma of nonalcoholic fatty liver disease in
Japan. Hepatol Int. 10:647–656. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Qin H, Sha J, Jiang C, Gao X, Qu L, Yan H,
Xu T, Jiang Q and Gao H: miR-122 inhibits metastasis and
epithelial-mesenchymal transition of non-small-cell lung cancer
cells. Onco Targets Ther. 8:3175–3184. 2015.PubMed/NCBI
|
|
45
|
Martins R, Lithgow GJ and Link W: Long
live FOXO: Unraveling the role of FOXO proteins in aging and
longevity. Aging Cell. 15:196–207. 2016. View Article : Google Scholar :
|
|
46
|
Lee S and Dong HH: FoxO integration of
insulin signaling with glucose and lipid metabolism. J Endocrinol.
233:R67–R79. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Morris BJ, Willcox DC, Donlon TA and
Willcox BJ: FOXO3: A major gene for human longevity - A
mini-review. Gerontology. 61:515–525. 2015. View Article : Google Scholar
|
